Low-dose ruxolitinib plus steroid in severe SARS-CoV-2 pneumonia.

D'Alessio, A; Del Poggio, P; Bracchi, F; Cesana, G; Sertori, N; Di Mauro, D; Fargnoli, A; Motta, M; Giussani, C; Moro, P; Vitale, G; Giacomini, M; Borra, G

D'Alessio, A; Del Poggio, P; Bracchi, F; Cesana, G; Sertori, N; Di Mauro, D; Fargnoli, A; Motta, M; Giussani, C; Moro, P; Vitale, G; Giacomini, M; Borra, G.

D'Alessio A; COVID Medical Department, Policlinico S.Marco Gruppo San Donato University and Research Hospital, Zingonia, Bergamo, Italy.
Del Poggio P; COVID Medical Department, Policlinico S.Marco Gruppo San Donato University and Research Hospital, Zingonia, Bergamo, Italy. paolo.delpoggio51@gmail.com.
Bracchi F; COVID Medical Department, Policlinico S.Marco Gruppo San Donato University and Research Hospital, Zingonia, Bergamo, Italy.
Cesana G; COVID Medical Department, Policlinico S.Marco Gruppo San Donato University and Research Hospital, Zingonia, Bergamo, Italy.
Sertori N; COVID Medical Department, Policlinico S.Marco Gruppo San Donato University and Research Hospital, Zingonia, Bergamo, Italy.
Di Mauro D; COVID Medical Department, Policlinico S.Marco Gruppo San Donato University and Research Hospital, Zingonia, Bergamo, Italy.
Fargnoli A; COVID Medical Department, Policlinico S.Marco Gruppo San Donato University and Research Hospital, Zingonia, Bergamo, Italy.
Motta M; COVID Medical Department, Policlinico S.Marco Gruppo San Donato University and Research Hospital, Zingonia, Bergamo, Italy.
Giussani C; COVID Medical Department, Policlinico S.Marco Gruppo San Donato University and Research Hospital, Zingonia, Bergamo, Italy.
Moro P; COVID Medical Department, Policlinico S.Marco Gruppo San Donato University and Research Hospital, Zingonia, Bergamo, Italy.
Vitale G; Intensive Care Unit, Policlinico S.Marco Gruppo San Donato University and Research Hospital, Zingonia, Bergamo, Italy.
Giacomini M; Intensive Care Unit, Policlinico S.Marco Gruppo San Donato University and Research Hospital, Zingonia, Bergamo, Italy.
Borra G; Policlinico S.Marco Gruppo San Donato University and Research Hospital, Zingonia, Bergamo, Italy.

Leukemia ; 35(2): 635-638, 2021 02.

Article in English | MEDLINE | ID: covidwho-1065835

Subject(s)

COVID-19 Drug Treatment; COVID-19/complications; Pneumonia, Viral/pathology; Pyrazoles/administration & dosage; SARS-CoV-2/isolation & purification; Steroids/administration & dosage; Adult; Aged; COVID-19/transmission; COVID-19/virology; Case-Control Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nitriles; Non-Randomized Controlled Trials as Topic; Pneumonia, Viral/epidemiology; Pneumonia, Viral/therapy; Pneumonia, Viral/virology; Prognosis; Pyrimidines

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Pyrazoles / Steroids / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment Type of study: Cohort study / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: Leukemia Journal subject: Hematology / Neoplasms Year: 2021 Document Type: Article Affiliation country: S41375-020-01087-z

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google